Intensity Therapeutics INTS Balance Sheet (2022-2026)

NASDAQ INTS
$4.88 +0.68 (+16.19%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 8.56M0.14M6.69M8.56M7.46M2.81M2.78M2.16M0.93M2.22M7.07M11.92M9.38M9.53M
Prepaid Assets (Quarter) 0.06M0.16M0.05M0.69M0.67M1.12M1.00M0.77M0.72M0.82M1.12M0.79M0.66M1.70M
Current Assets (Quarter) 1.45M18.06M16.63M15.46M11.17M7.44M3.79M3.36M1.65M3.04M8.19M12.71M10.91M11.23M
Non-Current Assets
Long-Term Deferred Tax (Quarter) 3.70M
Other Non-Current Assets (Quarter) 0.17M0.17M0.03M1.68M1.10M1.10M1.30M1.30M1.30M1.30M1.30M1.30M1.30M0.21M
Non-Current Assets (Quarter) 0.31M0.17M0.18M1.83M1.24M1.23M1.43M1.42M1.41M1.41M1.40M1.39M1.39M0.29M
Assets (Quarter) 1.76M18.23M16.82M17.30M12.41M8.67M5.21M4.78M3.06M4.44M9.59M14.10M12.29M11.52M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.60M1.58M0.36M3.05M1.22M1.92M0.54M1.22M1.59M1.19M1.68M0.58M0.64M1.01M
Notes Payables (Quarter) 4.35M
Payables (Quarter) 4.95M1.58M0.36M3.05M1.22M1.92M0.54M1.22M1.59M1.19M1.68M0.58M0.64M1.01M
Accumulated Expenses (Quarter) 1.72M0.89M1.48M0.36M0.89M1.27M1.26M1.75M0.51M1.01M0.94M0.56M1.53M1.57M1.20M
Other Accumulated Expenses (Quarter) 0.00M0.00M0.01M
Current Leases (Quarter) 0.14M0.01M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Total Current Liabilities (Quarter) 6.82M3.06M0.72M3.96M2.52M3.20M2.32M1.75M2.63M2.16M2.28M2.15M2.24M2.25M
Non-Current Liabilities
Capital Leases (Quarter) 0.14M
Convertible Debt (Quarter) 4.35M
Preferred Stock Liabilities (Quarter) 10.00M
Minority Interest (Quarter) 10.00M
Operating Leases (Quarter) 0.16M0.16M0.13M0.12M0.14M0.14M0.13M0.12M0.09M0.08M0.07M0.10M
Other Non-Current Liabilities (Quarter) 0.04M0.04M0.04M0.04M
Total Non-Current Liabilities (Quarter) 6.82M0.87M4.10M2.65M3.33M2.43M1.86M
Total Liabilities (Quarter) 6.86M3.09M0.90M4.13M2.69M3.33M2.43M1.86M2.73M2.26M2.36M2.23M2.31M2.31M
Shareholder's Equity
Common Equity (Quarter) -12.48M-14.21M-15.10M-15.96M15.13M15.91M13.16M9.72M5.34M2.78M2.92M0.33M2.18M7.22M11.88M9.98M9.21M
Liabilities and Shareholders Equity (Quarter) 1.76M18.23M16.82M17.30M12.41M8.67M5.21M4.78M3.06M4.44M9.59M14.10M12.29M11.52M
Retained Earnings (Quarter) -38.65M60.15M63.25M-50.52M64.84M-60.10M-63.60M-66.78M-70.10M-72.70M-75.34M-78.39M-80.80M93.04M
Treasury Shares (Quarter) 5.00M5.00M0.80M0.83M0.08M2.04M8.64M8.59M0.34M0.34M0.34M